SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $4,000 | -80.0% | 146 | -64.0% | 0.00% | -100.0% |
Q3 2018 | $20,000 | -16.7% | 406 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $24,000 | +26.3% | 406 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $19,000 | -9.5% | 406 | -23.5% | 0.00% | 0.0% |
Q4 2017 | $21,000 | -32.3% | 531 | -32.0% | 0.00% | 0.0% |
Q3 2017 | $31,000 | -6.1% | 781 | +2.5% | 0.00% | 0.0% |
Q2 2017 | $33,000 | +26.9% | 762 | -8.4% | 0.00% | 0.0% |
Q1 2017 | $26,000 | -21.2% | 832 | -36.5% | 0.00% | 0.0% |
Q4 2016 | $33,000 | -29.8% | 1,310 | -31.1% | 0.00% | -50.0% |
Q3 2016 | $47,000 | +6.8% | 1,902 | -12.4% | 0.00% | 0.0% |
Q2 2016 | $44,000 | +51.7% | 2,171 | +15.2% | 0.00% | +100.0% |
Q1 2016 | $29,000 | -14.7% | 1,884 | -25.2% | 0.00% | 0.0% |
Q4 2015 | $34,000 | -27.7% | 2,520 | -25.2% | 0.00% | -50.0% |
Q3 2015 | $47,000 | -17.5% | 3,369 | +0.6% | 0.00% | 0.0% |
Q2 2015 | $57,000 | +67.6% | 3,349 | +17.9% | 0.00% | +100.0% |
Q1 2015 | $34,000 | +78.9% | 2,840 | +25.7% | 0.00% | 0.0% |
Q4 2014 | $19,000 | +58.3% | 2,260 | +65.0% | 0.00% | – |
Q3 2014 | $12,000 | – | 1,370 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |